Fredrik Frejd PhD

Prof. Frejd has over fifteen years of experience in life science research with particular expertise in tumor biology, phage display and therapeutic protein engineering of antibody fragments and alternative scaffolds. He joined Affibody AB in 2002. Dr. Frejd is an adjunct professor at the unit for Biomedical radiation sciences, Uppsala University.